These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12873566)

  • 1. Barrett's esophagus evokes a quantitatively and qualitatively altered response to both acid and hypertonic solutions.
    Fletcher J; Gillen D; Wirz A; McColl KE
    Am J Gastroenterol; 2003 Jul; 98(7):1480-6. PubMed ID: 12873566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
    Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
    Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
    Singh P; Taylor RH; Colin-Jones DG
    Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease.
    Pfaffenbach B; Hullerum J; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
    Z Gastroenterol; 2000 Jul; 38(7):565-70. PubMed ID: 10965553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
    Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
    Brandt MG; Darling GE; Miller L
    Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication?
    Cowgill SM; Al-Saadi S; Villadolid D; Zervos EE; Rosemurgy AS
    Am J Surg; 2006 Nov; 192(5):622-6. PubMed ID: 17071195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
    Katzka DA; Castell DO
    Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
    Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
    Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls.
    Lottrup C; Krarup AL; Gregersen H; Ejstrud P; Drewes AM
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27891754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.